These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3886568)

  • 21. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the Medical Research Council Hypertension Trial.
    Dollery CT
    J Hypertens Suppl; 1987 Aug; 5(3):S75-8. PubMed ID: 3312530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrochlorothiazide and bendroflumethiazide in low doses--a comparative trial.
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():47-51. PubMed ID: 6369883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.
    Chamiec T; Bednarz B; Budaj A; Kłoś J; Pietrzykowska H; Zaleska T; Ceremuzyński L
    Mater Med Pol; 1990; 22(3):188-90. PubMed ID: 2132424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new beta-adrenergic blocking drug in hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1976 Feb; 216(1292):218-21. PubMed ID: 772659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
    Marshall AJ; Barritt DW; Pocock J; Heaton ST
    Lancet; 1977 Feb; 1(8006):271-4. PubMed ID: 64803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K; Sato K
    Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of MRC (UK) trial of drug therapy for mild hypertension.
    Peart S
    Clin Invest Med; 1987 Nov; 10(6):616-20. PubMed ID: 3326701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term usage of Prestim (timolol/bendrofluazide) in the management of mild to moderate hypertension in general practice.
    Hosie J; Jones JC; Clifford PD
    Br J Clin Pract; 1983; 37(11-12):393-6. PubMed ID: 6367796
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant effect of bendrofluazide on propranolol in hypertension.
    Mitchell I; Lodge R; Lawson AA
    Scott Med J; 1972 Oct; 17(10):326-9. PubMed ID: 4562883
    [No Abstract]   [Full Text] [Related]  

  • 34. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension].
    Wheatley D
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3278-81. PubMed ID: 768909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
    Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
    Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
    Wilcox RG
    Postgrad Med J; 1977; 53 Suppl 3():128-33. PubMed ID: 337267
    [No Abstract]   [Full Text] [Related]  

  • 40. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.